Home
/
FILANA THERAPEUTICS, INC.
/
Financials
/
Quarterly
FILANA THERAPEUTICS, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that FILANA THERAPEUTICS, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2014
Sep 30, 2013
$1.96M
Nov 5, 2014
Q2
2014
Jun 30, 2013
$1.96M
Aug 6, 2014
Q1
2014
Mar 31, 2013
$1.96M
May 7, 2014
Q3
2013
Sep 30, 2012
$2.73M
Nov 1, 2013
Q2
2013
Jun 30, 2012
$2.72M
Aug 1, 2013
Q1
2013
Mar 31, 2012
$2.97M
Apr 24, 2013
Q3
2012
Sep 30, 2011
$2.75M
Nov 9, 2012
Q2
2012
Jun 30, 2011
$2.75M
Aug 2, 2012
Q1
2012
Mar 31, 2011
$3.24M
May 8, 2012
Q3
2011
Sep 30, 2010
$2.90M
Nov 3, 2011
Q2
2011
Jun 30, 2010
$2.66M
Aug 4, 2011
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($10.81M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($44.22M)
Aug 14, 2025
Q3
2025
Jun 30, 2025
($44.22M)
Nov 12, 2025
Q2
2025
Mar 31, 2025
($23.40M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($23.40M)
May 8, 2025
Q3
2025
Mar 31, 2025
($23.40M)
Nov 12, 2025
Q3
2025
Sep 30, 2024
($27.94M)
Nov 12, 2025
Q3
2025
Jun 30, 2024
$6.16M
Nov 12, 2025
Q2
2025
Jun 30, 2024
$6.16M
Aug 14, 2025
Q3
2025
Mar 31, 2024
$25.04M
Nov 12, 2025
Q1
2025
Mar 31, 2024
$25.04M
May 8, 2025
Q2
2025
Mar 31, 2024
$25.04M
Aug 14, 2025
Q3
2024
Sep 30, 2023
($25.65M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($26.38M)
Aug 8, 2024
Q3
2024
Jun 30, 2023
($26.38M)
Nov 7, 2024
Q1
2024
Mar 31, 2023
($24.27M)
May 10, 2024
Q3
2024
Mar 31, 2023
($24.27M)
Nov 7, 2024
Q2
2024
Mar 31, 2023
($24.27M)
Aug 8, 2024
Q3
2023
Sep 30, 2022
($20.26M)
Nov 7, 2023
Q3
2023
Jun 30, 2022
($19.33M)
Nov 7, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($11.86M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($45.39M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($24.59M)
May 8, 2025
Q3
2025
Sep 30, 2024
($30.62M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($61.40M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($19.93M)
May 8, 2025
Q3
2024
Sep 30, 2023
($27.88M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($28.78M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($26.51M)
May 10, 2024
Q3
2023
Sep 30, 2022
($21.35M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($19.92M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($17.82M)
May 1, 2023
Q3
2022
Sep 30, 2021
($9.75M)
Nov 7, 2022
Q2
2022
Jun 30, 2021
($5.14M)
Aug 4, 2022
Q1
2022
Mar 31, 2021
($3.53M)
May 5, 2022
Q3
2021
Sep 30, 2020
($1.44M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($1.16M)
Aug 4, 2021
Q1
2021
Mar 31, 2020
($1.22M)
Apr 29, 2021
Q3
2020
Sep 30, 2019
($779.0K)
Nov 9, 2020
Q2
2020
Jun 30, 2019
($1.15M)
Aug 12, 2020